Brief: Emergent Biosolutions Receives $50 Million Contract Option From Barda To Procure Doses Of Cyfendus®

Emergent BioSolutions

16/12/2024 13:37

Dec 16 (Reuters) - Emergent BioSolutions Inc  EBS.N :
    * EMERGENT BIOSOLUTIONS RECEIVES $50 MILLION CONTRACT OPTION
FROM
BARDA TO PROCURE DOSES OF CYFENDUS® (ANTHRAX VACCINE ADSORBED,
ADJUVANTED)
    * CYFENDUS VACCINE DELIVERIES EXPECTED TO COMPLETE BY APRIL
2025

Source text:  ID:nGNX2hMRRX 
Further company coverage:  EBS.N 

 ((Reuters.Briefs@thomsonreuters.com;))